Session date: May 23, 2023
Multiple outcome measures are currently employed in the evaluation and management of patients with pulmonary hypertension (PH), creating confusion about which measure is most appropriate. In this session, we will discuss the state of the art approach to outcomes assessment in PH through in-depth analyses of the current and future measures of therapeutic response.
Multiple outcome measures are currently employed in the evaluation and management of patients with pulmonary hypertension (PH), creating confusion about which measure is most appropriate. In this session, we will discuss the state of the art approach to outcomes assessment in PH through in-depth analyses of the current and future measures of therapeutic response.
• Describe the strengths and weaknesses of currently employed outcome measures in pulmonary hypertension clinical trials
• Describe novel outcome measures that focus on "feels, functions, and survives" and how these may be applied in PH clinical trials
• More appropriately interpret and integrate results from clinical trials into clinical practice
Amy Gietzen
Stephen Mathai, MD, MHS
Hilary Dubrock, MD
Jasleen Minhas, MD, MS, MBBS
Steven Kawut, MD, MS, ATSF
Patient Perspective
The Emperor Has No Clothes: Current Outcome Measures in PH
Patient Reported Outcomes: The Missing Piece in Assessment of PH Outcomes
Walking in Circles: Functional Assessment as an Outcome Measure in PH
Risk Scores and Survival as Outcome Measures in PH